Jean‐Baptiste Bachet
0000-0003-4337-286X
Publication & Citation Trends
Publications
0 total
Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy
Cited by 0
Semantic Scholar
LAP-NET1: Phase 1b study investigating the association of NP137 with mFOLFIRINOX in locally advanced pancreatic ductal adenocarcinoma.
Cited by 0
Semantic Scholar
ALTOPANC: Local ablative therapies in oligometastatic pancreatic adenocarcinoma—A bi-national French-Belgian retrospective study.
Cited by 0
Semantic Scholar
Characteristics of KRAS WT pancreatic adenocarcinomas: results of a large French multicentric cohort
Cited by 0
Semantic Scholar
Medical management of pancreatic cancer: from personalization to broadening treatment strategies.
Cited by 11
Semantic Scholar
Abstract 3654: Comparative efficacy of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: computing IPTW estimator while limiting patient data exposure with federated learning across 3 institutions
Cited by 0
Semantic Scholar
Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials
Cited by 9
Semantic Scholar
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.
Cited by 1
Semantic Scholar
Research Topics
Pancreatic and Hepatic Oncology Research
(198)
Colorectal Cancer Treatments and Studies
(157)
Cancer Genomics and Diagnostics
(152)
Gastric Cancer Management and Outcomes
(75)
Genetic factors in colorectal cancer
(53)
Affiliations
Délégation Paris 5
Centre National de la Recherche Scientifique
Université Libre de Bruxelles
Inserm
Université Sorbonne Nouvelle